Generic Drugs Market Research Reports & Industry Analysis
Prescription generic pharmaceuticals are the non-patented chemical and therapeutic equivalents of brand-name drugs. These low-cost alternatives must contain the same active chemical ingredient and rate of absorption as the branded product. Due to high demand an increase in the number of generic drug approvals, the global generic drugs market has expanded at a steady pace over the years, and new growth opportunities are anticipated in the future. Check out our research collection to learn more about this lucrative market.
New Generic Drugs Industry Research
- Find quality data on industries big and small, whether you are interested in a specific product, region, or country.
- Gain in-depth research on generic drug market segmentation, patents, clinical trials, funding, and regulatory framework.
- Discover valuable new market opportunities, pockets of growth, and strategies to sustain success.
A Trusted Name in Research
MarketResearch.com offers a wealth of resources to propel your success through data-driven decision-making. We are proud to serve top investment banks, management consulting firms, leading life science companies, and universities—with a track record spanning decades and an experienced team to support your research needs. Explore our generic drugs industry reports today and embrace the power of foresight in an evolving market.
Generics Drugs Industry Research & Market Reports
-
Cephalosporin Market Forecasts to 2030 – Global Analysis By Generation (First-generation Cephalosporin, Second-generation Cephalosporin, Third-generation Cephalosporin, Fourth-generation Cephalosporin and Fifth-generation Cephalosporin), Type (Branded and Generic), Route of Administration, Distribution Channel, Dosage Form, Application and End User and By Geography.
... User and By Geography. According to Stratistics MRC, the Global Cephalosporin Market is accounted for $16.00 billion in 2023 and is expected to reach $22.97 billion by 2030 growing at a CAGR of 5.3% during ... Read More
-
Diagnostics and Therapeutics for HIV: Global Markets
... historic drug sales, regulations, reimbursements, and patents. The scope of this report includes an overview of the global market scenario for the diagnosis and treatment of HIV, with base year data from 2022, estimations for ... Read More
-
Generic Drug Market Forecasts to 2030 – Global Analysis By Product Type (Super Generics, Biosimilar Generics and Simple Generic), Route of Administration, Drug Class, Indication, Application, Distribution Channel, End User and By Geography
... Stratistics MRC, the Global Generic Drug Market is accounted for $396.8 billion in 2023 and is expected to reach $604.5 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Generic medications ... Read More
-
Global Finasteride Market Size Study & Forecast, by Type (Branded, Generic), by Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies), by Application (Benign Prostatic Hyperplasia (BPH), Male pattern baldness), and Regional Analysis, 2023-2030
... 2023-2030 Global Finasteride Market is valued at approximately USD 377.31 million in 2022 and is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2023-2030. Finasteride is a ... Read More
-
Ireland Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028
... (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028 Ireland Generic Drugs Market is expected to ... Read More
-
Malaysia Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region, Competition, Forecast and Opportunities, 2028
... Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), By Region, Competition, Forecast and Opportunities, 2028 A generic drug is a pharmaceutical drug that contains ... Read More
-
Canada Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028
... By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and By Region, Competition, Forecast, and Opportunities, 2028 Canada generic drugs market is anticipated to witness impressive growth during the forecast period. This can ... Read More
-
Argentina Generic Drugs Market by Type (Small Molecule, Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, and Others), By Form (Tablet, Capsule, Injection, and Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Application (Cardiovascular Disease, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), and By Region, Competition, Forecast, and Opportunities, 2028
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Application (Cardiovascular Disease, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, and Others), and By Region, Competition, Forecast, and Opportunities, 2028 The Argentina generic drugs market is anticipated to ... Read More
-
United States Generic Drugs Market By Type (Small Molecule Generics, Biosimilars), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Infectious Diseases, Others), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F
... Others), By Source (In House, Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast and& Opportunities, 2018-2028F United States Generic Drugs Market has valued at USD 104.23 ... Read More
-
Branded Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
... the forecast period, with an expected Compound Annual Growth Rate (CAGR) of 6.25% through 2028 and expected to reach USD 333.20 Billion in 2028. Branded generics, which are pharmaceutical drugs re-released under different brand names, ... Read More
-
Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition
... period with a CAGR of 5.01% through 2028. Computed tomography (CT) is a medical imaging technique that utilizes x-rays to generate cross-sectional images, or slices, of the anatomy. It involves the use of a scanner ... Read More
-
Oral Antibiotics Market By Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, Others), By Spectrum of Activity (Broad-spectrum Antibiotic, Mid/Narrow-spectrum antibiotic), By Application (Community-acquired respiratory tract infections (CARTIs), Urinary tract infections (UTIs), Dental, Others), By Drug Origin (Natural, Semisynthetic, Synthetic), By Drug Type (Branded, Generic): Global Opportunity Analysis and Industry Forecast, 2023-2032
... By Drug Origin (Natural, Semisynthetic, Synthetic), By Drug Type (Branded, Generic): Global Opportunity Analysis and Industry Forecast, 2023-2032 The Oral Antibiotics Market was valued at $22,468.27 million in 2022 and is estimated to reach $28,819.98 ... Read More
-
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 Including: 1) By Drug Class: Nerve Protective Therapy; Anti-Inflammatory Therapy; Neurotransmitter Based Therapy; Antioxidantes 2) By Treatment: Medication; Therapy 3) By Drug Type: Branded; Generic 4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacies 5) By End-User: Hospitals; Research Institutes; Specialty Clinics Covering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc.
... Hospital Pharmacy; Retail Pharmacy; Online Pharmacies5) By End-User: Hospitals; Research Institutes; Specialty ClinicsCovering: Sanofi SA; Bristol Myers Squibb; Abbott Laboratories; Takeda Pharmaceutical Company; Amgen Inc. Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023 from ... Read More
-
U.S. Generic Injectables Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report By Molecule Type (Small Molecule, Large Molecule), By Application, And Segment Forecasts, 2023 - 2030
... Growth & Trends The U.S. generic injectables pharmaceutical contract manufacturing market size is expected to reach USD 5.39 billion by 2030, according to a new report by Grand View Research, Inc. The U.S. market is ... Read More
-
Pharmaceutical Quality Management Systems Market by Solution Type (Deviation, CAPA, Audit, Risk & Compliance, Inspection, Document, Change, Training Management), Deployment Mode (Cloud, On-premise), and End User (Pharmaceutical, CDMO/CRO) - Global Forecast to 2030
... systems market is expected to reach $3.97 billion by 2030, at a CAGR of 15.6% from 2023 to 2030. Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report studies ... Read More
-
Israel Generic Drugs Market, By Type (Pure Generic Drugs, Branded Generic Drugs), By Application (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), By Drug Delivery (Oral, Injectables, Dermal/Topical, and Inhalers), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies), By Region, Competition, Forecast & Opportunities, 2028
... (Retail Pharmacies, Hospital Pharmacies), By Region, Competition, Forecast & Opportunities, 2028 Israel Generic Drugs Market is anticipated to witness substantial growth through 2028, owing to the incorporation of artificial intelligence (AI) in healthcare technologies for ... Read More
-
Pharmaceutical Contract Manufacturing Market Size, Share, and Analysis, By Molecule Type (Small Molecules, Large Molecules), By Service (Pharmaceutical Manufacturing Services, Pharmaceutical API Manufacturing Services, Pharmaceutical FDF Manufacturing Services, Drug Development Services, Biologic Manufacturing Services, Biologic API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032.
... API Manufacturing Services, Biologic FDF Manufacturing Services), By End User (Big Pharmaceutical Companies, Small & Mid-Sized Pharmaceutical Companies, Generic Pharmaceutical Companies, Other End Users [Academic Institutes, Small CDMOs, and CROs]) and Regional Forecasts, 2022-2032. Pharmaceutical ... Read More
-
Branded Generics Market - By Drug Class (Anti-hypertensive, Hormones, Antimetabolites), Application (Oncology, Cardiovascular Diseases), Route of Administration (Oral, Topical), Distribution Channel (Hospital Pharmacy), Global Forecast, 2023 - 2032
... an appreciable growth rate between 2023 and 2032. Government initiatives aimed at promoting generic products can have a stimulating effect on the market. In September 2023, the Swiss government approved changes to the Ordinance on ... Read More
-
Global Generic Drug Intermediates CDMO Services Market Growth (Status and Outlook) 2023-2029
... and recovery from influence of COVID-19 and the Russia-Ukraine War, the Plastics Colouration Masterbatch is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. The research ... Read More
-
Global Generic Drug Research and Development Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Generic Drug Research and Development Services refers ... Read More
-
Global Generic Drug Research and Development Services Market Growth (Status and Outlook) 2023-2029
... With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the LED Turn Signal Lights for Motorcycles is forecast to a readjusted size of US$ million by 2029 with ... Read More
-
Global Generic Drug Consistency Evaluation Service Market Growth (Status and Outlook) 2023-2029
... downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Forward Facing ADAS Camera is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review ... Read More
-
Global Generic Drug Intermediates CDMO Services Market 2023 by Company, Regions, Type and Application, Forecast to 2029
... valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. Generic Drug Intermediates CDMO (Contract Development and Manufacturing Organization) ... Read More
-
Global Generic Drug Research and Development Services Supply, Demand and Key Producers, 2023-2029
... growth of % CAGR during the forecast period (2023-2029). Generic Drug Research and Development Services refers to a service that supports pharmaceutical companies in the process of developing generic drugs. It involves a range of ... Read More
-
Global Generic Drug Intermediates CDMO Services Supply, Demand and Key Producers, 2023-2029
... % CAGR during the forecast period (2023-2029). The market prospects for Generic Drug Intermediates CDMO (Contract Development Manufacturing Organization) Services are expected to be strong. The demand for generic drugs continues to rise due to ... Read More
Research Assistance
